June 4, 2018 – Department of Defense Medical Innovation and Biodefense Forum, BIO 2018! at Boston Convention & Exhibition Center
Announcement
Aviva Lev-Ari, PhD, RN,
https://mybio.org/profile/member/2029564?profile_tabs=profile
Founder and Director of LPBI Group will be in attendance covering the event in REAL TIME
@pharma_BI
@AVIVA1950
for
#BIO2018
#MakingBIOHistory
@BIOConvention
9:00 AM–12:00 PM Jun 4, 2018
- How DoD can assist Industry to commercialize technologies
- How the coordination in the Infectious disease takes place
- Manufacturing for DoD
- Infrastructure to manage across Government RFP Process
- Devices requires detailed engineering for use in Field hospitals
- Regulatory, Scheduling and Engineering problems
- Development is for all the Forces of the US and for all the Forces of US Allies — design for CIvilian first respnders as well
- Some partners are commercial Partners, they need to approach DoD with novel product concept
- FDA approved vs Right to Try – DoD uses both
Panel 1: Captain Joseph Cohn Chief, Research Program Administration Division J9, Research & Development Directorate at Defense Health Agency (DHA)
- Small business Program, success in bringing product to market
- 20 years ago: Communities of interest – 20 orgs community common goals in Health Care, rehabilitation after coming home,
- MROC – Conference in Florida DoD to explain the Public the process of engagement with Do
Moderator , Panel 3: Hannah Feldman Public Affairs Specialist atJoint Program Executive Office for Chemical and Biological Defense, Medical Countermeasure Systems
- Interagency partnership
Moderator, Panel 2: Tom Handel General Manager and President at Meridian Medical Technologies, Inc.
Panel 1 & 2 & 3: Dr. David Hone Chief Scientist, Vaccine and Therapeutic Division, Joint Science and Technology Office atDefense Threat Reduction Agency
- DoD starts with good ideas, concept studies – innovators
- Collaborations with Academia, we are available to be approached
- DoD will partner with small businesses to avoid the Regulatory process – to save time and resources in the commercialization process
- How a civilian concept FITS the needs of DoD
- Sustaining an innovation along the years
- Need for small business to approach DoD to make the contact
- Where is a small business in the Development cycle? DoD can help calibrate
- A System of Systems: Diagnostics drive decisions
- develop partnerships in consortia
- Six month to vaccinate 17,000 with a Vaccine for EBOLA
- DoD of respective countries are collaborating with US DoD
- Threat environment changes over time vs modify known threats
- Monoclonal antibody – the Industry developed the manufacturing technology and DoD is user of Industry products
- All research for the Joint Force, Chemical, Biological,
- Short time to market solutions are of interest for DoD to identify
- Military relevance: Key for funding
- Announcements of DoD on WHAT PROBLEMS DoD tries to solve
- DoD and HHS — aligned for common solution to avoid redundancy
- Development of profilaxix is very expensive, DoD budget has competing goals: Next soldier suit,
- FDA and DoD need to collaborate for DoDs needs
- Order transaction authority,
- Congress set aside a budget for small businesses to use accounting systems for Small business to interact with DoD
- How to get a digital signal to the brain: Expertise in many disciplines: EE, Ethomology
- Delivery, test , evaluation, develop sensors, IS to manage threats, Diagnostics,
- How to do Business with Industry?
- Congress asked for a Consorsium to engage with Industry in a different form than we engaged before
- Partnerships for out of the box thinking and going quickly – the appetite for is greater then evr before
- Successful area: Diagnostics – adoptation of existing diagnostics for military applications
- Platform technologies: Metabolic, Vaccines,
- Leverage existing technologies to solve DoD concerns
- involved with MCS help Government to learn how to build their Office
- Genomic, Proteomics, therapeutics candidates, Prophylaxis as Vaccines
- In the event of an outbreak: clinicians, 1st responders
Panel 2: Clay Holloway, Director of Strategic Initiatives, Joint Project Manager, Medical Countermeasure Systems (JPM-MCS)
- Partnering is key
- capability requirements: broad spectrum capabilities
- Decision tools to be used at studies for data analysis for decision making
- Risks in partnership: DoD needs to evaluate ideas for next generation to SKIP one generation
- How to used different agreement strategically? Streamline DoD Methods
- Have continuous access to assets
LOCATION
Leave a Reply